{"url":"https://lda.senate.gov/api/v1/filings/d244e9d7-9f2f-4ee4-bf0d-5fa7a42a7934/","filing_uuid":"d244e9d7-9f2f-4ee4-bf0d-5fa7a42a7934","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2025,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/d244e9d7-9f2f-4ee4-bf0d-5fa7a42a7934/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Niki Carelli","dt_posted":"2025-04-21T21:27:32-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"901 K Street, NW","registrant_address_2":"Suite 900","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":401108299,"url":"https://lda.senate.gov/api/v1/registrants/401108299/","house_registrant_id":56414,"name":"DB3, LLC (FKA THE DASCHLE GROUP)","description":null,"address_1":"901 K Street, NW","address_2":"Suite 900","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"SHAWNTAY CHARLES","contact_telephone":"+1 202-508-3412","dt_updated":"2026-07-15T14:24:57.388428-04:00"},"client":{"id":59189,"url":"https://lda.senate.gov/api/v1/clients/59189/","client_id":59189,"name":"BIPARTISAN COMMISSION ON BIODEFENSE","general_description":"Biodefense study panel","client_government_entity":null,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2024-03-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Funding and prioritization of biodefense preparedness and response, generally; policy recommendations related to biodefense preparedness and response; reauthorization of the Pandemic and All-Hazards Preparedness Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145583,"prefix":null,"prefix_display":null,"first_name":"NICOLE","nickname":null,"middle_name":null,"last_name":"CARELLI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"AGR","general_issue_code_display":"Agriculture","description":"Issues related to preparedness for H5N1.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145583,"prefix":null,"prefix_display":null,"first_name":"NICOLE","nickname":null,"middle_name":null,"last_name":"CARELLI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}